EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Fetal Environment and the Development of Hypertension—The Epigenetic Modification by Glucocorticoids

Fumiko-Kawakami Mori, Tatsuo Shimosawa iD

International Journal of Molecular Sciences · 06.01.2025 · 26 (1) · 420

DOI: 10.3390/ijms26010420 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.01.2025. Verfasst von Fumiko-Kawakami Mori und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Mitsui Memorial Hospital, Tokyo 101-8643, Japan. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Glucocorticoids, Hypertension, DNA Methylation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intrauterine growth restriction (IUGR) is a risk factor for postnatal cardiovascular, metabolic, and psychiatric disorders. In most IUGR models, placental dysfunction that causes reduced 11β-hydroxysteroid dehydrogenase 2 (11βHSD2) activity, which degrades glucocorticoids (GCs) in the placenta, resulting in fetal GC overexposure. This overexposure to GCs continues to affect not only intrauterine fetal development itself, but also the metabolic status and neural activity in adulthood through epigenetic changes such as microRNA change, histone modification, and DNA methylation. We have shown that the IUGR model induced DNA hypomethylation in the paraventricular nucleus (PVN) in the brain, which in turn activates sympathetic activities, the renin–angiotensin system (RAS), contributing to the development of salt-sensitive hypertension. Even in adulthood, strong stress and/or exogenous steroids have been shown to induce epigenetic changes in the brain. Furthermore, DNA hypomethylation in the PVN is also observed in other hypertensive rat models, which suggests that it contributes significantly to the origins of elevated blood pressure. These findings suggest that if we can alter epigenetic changes in the brain, we can treat or prevent hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticGlucocorticoidsHypertensionDNA MethylationAnimalsHumansPregnancyFemaleFetal Growth RetardationRenin-Angiotensin System11-beta-Hydroxysteroid Dehydrogenase Type 2

Stichwörter der Autor:innen

DNA methylationblood pressuredevelopmental origins of health and disease (DOHaD)environmentepigeneticshypothalamus

Substanzen

Glucocorticoids11-beta-Hydroxysteroid Dehydrogenase Type 2

Autor:innen und Institutionen

  • Department of Endocrinology, Mitsui Memorial Hospital, Tokyo 101-8643, Japan.
  • Department of Clinical Laboratory, School of Medicine, International University of Health and Welfare, Otawara 324-8501, Japan.

ORCID-Profile: Tatsuo Shimosawa

Zitieren

APA

Mori, F. K., & Shimosawa, T. (2025). The Fetal Environment and the Development of Hypertension—The Epigenetic Modification by Glucocorticoids. International Journal of Molecular Sciences, 26(1), 420. https://doi.org/10.3390/ijms26010420

Vancouver

Mori FK, Shimosawa T. The Fetal Environment and the Development of Hypertension—The Epigenetic Modification by Glucocorticoids. International Journal of Molecular Sciences. 2025;26(1):420. doi:10.3390/ijms26010420

BibTeX
@article{Mori2025,
  author = {Mori, Fumiko-Kawakami and Shimosawa, Tatsuo},
  title = {The Fetal Environment and the Development of Hypertension—The Epigenetic Modification by Glucocorticoids},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {1},
  pages = {420},
  doi = {10.3390/ijms26010420}
}
Kostenlos starten →